Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04449341 · ClinicalTrials.gov registry record · NA
Can Virtual Reality Reduce Pain and Anxiety During Blood Draw
A NA study of Procedural Pain and Procedural Anxiety, sponsored by C.R.Darnall Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT04449341: Completed NA study of Procedural Pain and Procedural Anxiety, sponsored by C.R.Darnall Army Medical Center.
NCT04449341 is a NA study of Procedural Pain and Procedural Anxiety that has completed, run by C.R.Darnall Army Medical Center. The registered enrollment target is 59 participants, roughly in line with the 55-participant average among 9 other Procedural Pain trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04449341, a NA study of Procedural Pain and Procedural Anxiety, has completed, sponsored by C.R.Darnall Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
Adult patients aged 18-50 undergoing blood draw for routine lab evaluation will be randomized to a control group or experimental group to assess if the use of virtual reality reduces procedural pain (primary outcome) and procedural anxiety (secondary outcome) during venipuncture.
Primary Outcome
Determine if use of Oculus Go headset reduces procedural pain perception utilizing the visual analog scale, which measures pain on a linear scale from 0 to 100 millimeters, with 0 being no pain and 100 being maximum pain
Conditions Studied
Interventions
- DEVICE Oculus Go headset with Ocean Rift application
Study Locations (1)
Texas
- Carl R Darnall Army Medical Center - Fort Hood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2020-06-10 |
| Est. Completion | 2020-07-09 |
| Phase | NA |
What the finished NCT04449341 record still lists
NCT04449341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, roughly in line with the 55-participant average among 9 other Procedural Pain trials with a reported enrollment target.
The record links to 2 conditions, with Procedural Pain appearing as the primary indexed condition, and to 1 intervention - of which Oculus Go headset with Ocean Rift application is the first listed.
NCT04449341 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04449341 about?
NCT04449341 is a clinical study titled "Can Virtual Reality Reduce Pain and Anxiety During Blood Draw". Adult patients aged 18-50 undergoing blood draw for routine lab evaluation will be randomized to a control group or experimental group to assess if the use of virtual reality reduces procedural pain (primary outcome) and procedural anxiety (secondary outcome) during venipuncture.
What is the current status of trial NCT04449341?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2020-06-10. Estimated completion is 2020-07-09.
What conditions does trial NCT04449341 study?
This clinical trial studies the following conditions: Procedural Pain, Procedural Anxiety.
What interventions are being tested in trial NCT04449341?
The interventions under investigation include: Oculus Go headset with Ocean Rift application (DEVICE).
Who is sponsoring clinical trial NCT04449341?
This trial is sponsored by C.R.Darnall Army Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04449341 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Procedural Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04449341's enrollment target sits among peer trials
59 4th of 9 higher than 6 of 9 other Procedural Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Procedural Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cervical Preparation for Same-Day Dilation & Evacuation
RECRUITING · NA
-
Trauma-Informed Procedural Pain Intervention: Refinement of an Evidence-Based Protocol
RECRUITING · NA
-
Oral Surgery Virtual Reality Glasses Study
RECRUITING · NA
-
Virtual Reality for Pain Control in US-Guided Obstetric Needle Procedures
RECRUITING · NA
-
VR-PAT for Pain and Anxiety Management During Pediatric Dermatologic Laser Procedures
ACTIVE NOT RECRUITING · NA
-
Comparison of Compounded Topical Anesthetics
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI